Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.37B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$488M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$449M |
| 4 |
Apple
AAPL
|
+$402M |
| 5 |
HES
Hess
HES
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.47B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$1.44B |
| 3 |
NVIDIA
NVDA
|
+$783M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$722M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$650M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Healthcare | 6.09% |
| 3 | Financials | 5% |
| 4 | Consumer Discretionary | 4.53% |
| 5 | Industrials | 4.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.3B
| $1.38M | ﹤0.01% |
40,631
+20,979
| +107% | +$666K |
|
|
CPE
3802
CALL
DELISTED
Callon Petroleum Company
CPE
| $1.38M | ﹤0.01% |
+42,600
| New | +$1.46M |
|
3803
PUT
British American Tobacco
BTI
$131B
| $1.38M | ﹤0.01% |
47,100
+3,700
| +9% | +$113K |
|
3804
iShares MSCI Saudi Arabia ETF
KSA
$623M
| $1.38M | ﹤0.01% |
32,589
| – | – |
|
3805
Mercury Systems
MRCY
$5.83B
| $1.38M | ﹤0.01% |
37,691
-58,378
| -61% | -$2.11M |
|
3806
GCM Grosvenor
GCMG
$754M
| $1.38M | ﹤0.01% |
153,760
-101,014
| -40% | -$841K |
|
3807
CALL
Veracyte
VCYT
$3.7B
| $1.38M | ﹤0.01% |
50,000
-50,000
| -50% | -$1.21M |
|
|
JKS
3808
PUT
JinkoSolar
JKS
$793M
| $1.37M | ﹤0.01% |
+37,200
| New | +$1.2M |
|
|
CYT
3809
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $1.37M | ﹤0.01% |
+451,980
| New | +$1.37M |
|
3810
Pinnacle Financial Partners Inc
PNFP
$15.9B
| $1.37M | ﹤0.01% |
15,722
-438,854
| -97% | -$31.8M |
|
|
APLS
3811
PUT
DELISTED
Apellis Pharmaceuticals
APLS
| $1.37M | ﹤0.01% |
22,900
-80,500
| -78% | -$4.08M |
|
3812
CALL
Air Products & Chemicals
APD
$65.7B
| $1.37M | ﹤0.01% |
5,000
-51,300
| -91% | -$14.1M |
|
3813
Prothena Corp
PRTA
$425M
| $1.37M | ﹤0.01% |
37,656
-227,869
| -86% | -$8.77M |
|
3814
Limbach Holdings
LMB
$855M
| $1.37M | ﹤0.01% |
30,055
-84,499
| -74% | -$3.03M |
|
3815
iShares S&P 100 ETF
OEF
$20.1B
| $1.37M | ﹤0.01% |
6,113
-3,158
| -34% | -$664K |
|
3816
Ultragenyx Pharmaceutical
RARE
$2.45B
| $1.37M | ﹤0.01% |
28,552
-80,396
| -74% | -$3.12M |
|
3817
1stdibs.com
DIBS
$149M
| $1.37M | ﹤0.01% |
291,672
+8,466
| +3% | +$35.7K |
|
3818
Gilat Satellite Networks
GILT
$834M
| $1.36M | ﹤0.01% |
223,280
+54,397
| +32% | +$338K |
|
3819
CALL
Smith & Nephew
SNN
$13.3B
| $1.36M | ﹤0.01% |
50,000
| – | – |
|
|
FLIC
3820
DELISTED
First of Long Island Corp
FLIC
| $1.36M | ﹤0.01% |
102,925
+91,880
| +832% | +$1.07M |
|
3821
Dr. Reddy's Laboratories
RDY
$9.87B
| $1.36M | ﹤0.01% |
97,795
-1,710,245
| -95% | -$22.9M |
|
3822
PUT
GSK
GSK
$104B
| $1.36M | ﹤0.01% |
36,700
+3,400
| +10% | +$122K |
|
3823
Hippo Holdings
HIPO
$830M
| $1.36M | ﹤0.01% |
148,928
+132,969
| +833% | +$1.1M |
|
3824
Bluerock Homes Trust
BHM
$35.3M
| $1.36M | ﹤0.01% |
97,041
-22,761
| -19% | -$318K |
|
3825
RingCentral
RNG
$4.66B
| $1.36M | ﹤0.01% |
39,914
-43,701
| -52% | -$1.31M |
|
Similar funds
Millennium Management's Q4 2023 Portfolio in Review
As of Q4 2023, Millennium Management held 6,891 positions worth $231B, up 17% from $198B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Millennium Management deployed $7.99B of net new capital in Q4 2023, opening 816 new positions and adding to 2,304 existing holdings. Its largest new stake was Ferguson: 906,589 shares worth $175M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 9.2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.47B trimmed.
- Millennium Management's largest Q4 2023 buy was Ferguson: 906,589 shares worth $175M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $4.37B increase.
- Millennium Management's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.47B.
- Millennium Management fully exited Activision Blizzard in Q4 2023, selling an estimated $1.44B.
- Millennium Management's ten largest holdings make up 21% of its $231B portfolio in Q4 2023.
- Millennium Management opened 816 new positions and closed 883 in Q4 2023.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $231B.
Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.